Clinical Trials on B-cell Chronic Lymphocytic Leukemia
Total 7884 results
-
Nanfang Hospital of Southern Medical UniversityNot yet recruitingChronic Lymphocytic Leukemia
-
National Taiwan University HospitalRecruitingChronic Lymphocytic LeukemiaTaiwan
-
Institute of Hematology & Blood Diseases HospitalRecruitingChronic Lymphocytic LeukemiaChina
-
AbbVieCompletedChronic Lymphocytic LeukemiaUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Ireland, Israel, Italy, Netherlands, Norway, Portugal, Puerto Rico, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteTG Therapeutics, Inc.TerminatedChronic Lymphocytic LeukemiaUnited States
-
University of UlmAbbVie; Roche Pharma AG; Janssen-Cilag Ltd.; German CLL Study GroupCompletedLeukemia, Lymphocytic, ChronicGermany
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Gruppo Italiano Malattie EMatologiche dell'AdultoERIC GroupCompleted
-
Grupo Espanol de trasplantes hematopoyeticos y...GlaxoSmithKlineCompleted
-
Arbeitsgemeinschaft medikamentoese TumortherapieMundipharma Pte Ltd.CompletedLeukemia, Lymphocytic, Chronic, B-CellAustria
-
ItalfarmacoTerminatedChronic Lymphocytic LeukemiaItaly
-
German CLL Study GroupCelgeneCompletedChronic Lymphocytic LeukemiaGermany
-
Memgen, LLCUniversity of California, San Diego; The Leukemia and Lymphoma SocietyCompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterCompletedIdentifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)Leukemia | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Lymphocytic LeukemiaUnited States
-
Joseph TuscanoGlaxoSmithKlineCompletedChronic Lymphocytic LeukemiaUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedChronic Lymphocytic LeukemiaItaly
-
Boehringer IngelheimCompletedLeukemia, Lymphocytic, Chronic, B-CellGermany, Belgium, France
-
German CLL Study GroupGilead Sciences; Novartis PharmaceuticalsCompletedChronic Lymphocytic LeukemiaGermany
-
M.D. Anderson Cancer CenterBristol-Myers SquibbCompletedLeukemia | Chronic Lymphocytic Leukemia | Lymphocytic LeukemiaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedLeukemiaUnited States, Canada
-
Hoffmann-La RocheCompletedChronic Lymphocytic LeukemiaArgentina
-
Gilead SciencesCompletedChronic Lymphocytic LeukemiaUnited States, Hungary, Belgium, United Kingdom, France, Australia, Turkey, Croatia, Italy, Poland, Canada, Greece, Czechia, Ireland, Russian Federation, Spain, Portugal, Romania
-
M.D. Anderson Cancer CenterCompletedChronic Lymphocytic LeukemiaUnited States
-
Genentech, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedChronic Lymphocytic LeukemiaUnited States
-
Pirogov Russian National Research Medical UniversityUnknownChronic Lymphocytic LeukemiaRussian Federation
-
Gilead SciencesTerminatedChronic Lymphocytic LeukemiaUnited States, Spain, Belgium, Canada, United Kingdom, Australia, Denmark, Poland, Ireland, France, Sweden
-
University of California, San DiegoBristol-Myers SquibbTerminatedChronic Lymphocytic LeukemiaUnited States
-
German CLL Study GroupCompletedChronic Lymphocytic LeukemiaGermany, Austria
-
Scripps HealthBristol-Myers Squibb; Celgene CorporationWithdrawnLeukemia | Chronic Lymphocytic Leukemia
-
Hoffmann-La RocheCompletedLeukemia, Lymphocytic, Chronic, B-CellSpain
-
M.D. Anderson Cancer CenterBayerCompletedLeukemiaUnited States
-
German CLL Study GroupCompletedChronic Lymphocytic LeukemiaGermany, Austria
-
University of California, San DiegoGenentech, Inc.; Celgene CorporationWithdrawnChronic Lymphocytic LeukemiaUnited States
-
Massachusetts General HospitalBristol-Myers Squibb; Dana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheGenentech, Inc.; BiogenCompletedChronic Lymphocytic LeukemiaUnited States, Italy, Belgium, Canada, Spain, Australia, France, Russian Federation, Netherlands, New Zealand, Denmark, Romania, Poland, Hungary, United Kingdom, Sweden, Norway
-
Roswell Park Cancer InstituteCelgeneCompleted
-
Hoffmann-La RocheCompletedChronic Lymphocytic LeukemiaHungary
-
University Health Network, TorontoCelgene CorporationCompleted
-
Duke UniversityGilead Sciences; Genentech, Inc.; Med-IQCompletedChronic Lymphocytic LeukemiaUnited States
-
German CLL Study GroupTerminatedChronic Lymphocytic Leukemia
-
Genzyme, a Sanofi CompanyCompletedLeukemia, Lymphocytic, Chronic, B-CellUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLeukemiaUnited States
-
Dana-Farber Cancer InstituteGenzyme, a Sanofi CompanyCompletedChronic Lymphocytic LeukemiaUnited States
-
University of PittsburghGenentech, Inc.; BiogenCompletedChronic Lymphocytic LeukemiaUnited States
-
Janssen PharmaceuticaWithdrawn
-
Northwell HealthBayerTerminated
-
BiogenTerminatedChronic Lymphocytic LeukemiaFrance, United States, Belgium, Australia, Austria, Poland, Canada, United Kingdom